Investor List:

Top BioTech Series B Investors in Washington, D.C. (9)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top BioTech investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Ali Behbahani, General Partner at New Enterprise Associates (NEA)
Ali Behbahani
Sweet spot: $25.0M
Range: $2.0M - $50.0M
Investors in Washington (DC)
Photo of Ed Mathers, Partner at New Enterprise Associates (NEA)
Ed Mathers
Sweet spot: $25.0M
Range: $2.0M - $50.0M
Investors in Maryland, Investors in Washington (DC)
Photo of Scott Gottlieb, Partner at New Enterprise Associates (NEA)
Scott Gottlieb
Sweet spot: $25.0M
Range: $2.0M - $50.0M
Investors in Washington (DC)
Photo of George C. Petrocheilos, Managing Partner at Catalio Capital
George C. Petrocheilos
Catalio Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD), Investors in Athens (Greece), Investors in New York (NY)
Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Robotics (Series B), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in Robotics (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Robotics (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in Robotics (Series A), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Washington, D.C. (Other Lists), Investors in Cybersecurity (Seed), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Seed), Investors in Cybersecurity (Series A), Investors in Cybersecurity (Series B), Investors in Cybersecurity (Series B), Investors in Cybersecurity (Series A), Investors in Diagnostics (Series B), Investors in Cybersecurity (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Cybersecurity (Series A), Investors in Cybersecurity (Seed), Investors in Cybersecurity (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed)
Photo of Henri Yuan, Investor at Alumni Ventures
Henri Yuan
Sweet spot: $500K
Range: $50K - $10.0M
Investors in Washington (DC)
Investors in GovTech (Seed), Investors in Data Services (Series B), Investors in BioTech (Series B), Investors in GovTech (Series B), Investors in GovTech (Series A), Investors in Data Services (Seed), Investors in Marketplaces (Series B), Investors in Data Services (Series A), Investors in Enterprise (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Diverse Investors (Other Lists), Investors in Health IT (Series A), Investors in Investors who invested in female founders (Other Lists), Investors in Marketplaces (Series A), Investors in BioTech (Seed), Investors in SaaS (Series B), Investors in Investors who invested in diverse founders (Other Lists), Investors in Data Services (Seed), Investors in Enterprise (Seed), Investors in Enterprise (Series A), Investors in GovTech (Seed), Investors in Health IT (Seed), Investors in Marketplaces (Seed), Investors in SaaS (Seed), Investors in BioTech (Series A), Investors in Data Services (Series A), Investors in Enterprise (Series A), Investors in GovTech (Series A), Investors in Health IT (Series A), Investors in Marketplaces (Series A), Investors in SaaS (Series A), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Data Services (Series B), Investors in Marketplaces (Series B), Investors in GovTech (Series B), Investors in Health IT (Series B), Investors in SaaS (Series B), Investors in Washington, D.C. (Other Lists), Investors in Future of Work (Series B), Investors in Future of Work (Series A), Investors in Future of Work (Seed), Investors in Cybersecurity (Seed), Investors in Cybersecurity (Series A), Investors in Cybersecurity (Series B), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in Cybersecurity (Series B), Investors in Enterprise Applications (Series A), Investors in Cybersecurity (Series A), Investors in Cybersecurity (Seed), Investors in Enterprise Applications (Seed), Investors in Enterprise Applications (Series B), Investors in Enterprise Applications (Series B), Investors in Enterprise Applications (Series A), Investors in Enterprise Applications (Seed), Investors in SaaS (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Marketplaces (Seed), Investors in SaaS (Seed), Investors in Enterprise (Seed)
Photo of R. Jacob Vogelstein, Managing Partner at Catalio Capital
R. Jacob Vogelstein
Catalio Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Washington (D.C.), Investors in Baltimore (MD), Investors in Bethesda
Investors in AI (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Medical Devices (Series B), Investors in Washington, D.C. (Other Lists), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B)
Photo of Jason Gabriel, Managing Director at Syngenta Group Ventures
Jason Gabriel
Syngenta Group Ventures·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Blacksburg (VA)
Investors in AgTech (Series B), Investors in AgTech (Series A), Investors in BioTech (Series B), Investors in AgTech (Seed), Investors in E-commerce (Series B), Investors in E-commerce (Series A), Investors in Marketplaces (Series B), Investors in BioTech (Seed), Investors in FinTech (Series B), Investors in AgTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Marketplaces (Series A), Investors in E-commerce (Seed), Investors in E-commerce (Seed), Investors in FinTech (Seed), Investors in Marketplaces (Seed), Investors in AgTech (Series A), Investors in BioTech (Series A), Investors in E-commerce (Series A), Investors in FinTech (Series A), Investors in Marketplaces (Series A), Investors in BioTech (Series B), Investors in AgTech (Series B), Investors in E-commerce (Series B), Investors in Marketplaces (Series B), Investors in FinTech (Series B), Investors in Washington, D.C. (Other Lists), Investors in FinTech (Series A), Investors in FinTech (Seed), Investors in Marketplaces (Seed)
Photo of Doug Smith, Partner at Roo Partners
Doug Smith
Roo Partners·Partner
Sweet spot: $13.0M
Range: $1M - $25.0M
Investors in Washington (DC)
Investors in Retail (Seed), Investors in BioTech (Series B), Investors in Consumer Internet (Series B), Investors in Retail (Series A), Investors in BioTech (Seed), Investors in Retail (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Consumer Internet (Seed), Investors in Health IT (Seed), Investors in Retail (Seed), Investors in Health & Hospital Services (Series A), Investors in Consumer Internet (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Consumer Internet (Series A), Investors in Health IT (Series A), Investors in Retail (Series A), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in Consumer Internet (Series B), Investors in Health IT (Series B), Investors in Retail (Series B), Investors in Health & Hospital Services (Series B), Investors in Washington, D.C. (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Retail (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Consumer Internet (Pre-seed), Investors in Health IT (Pre-seed), Investors in Retail (Pre-seed), Investors in Consumer Internet (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Consumer Internet (Series A), Investors in Health IT (Seed), Investors in BioTech (Pre-seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Get new data & insights delivered to your inbox